Show simple item record

dc.contributor.advisorDube, Admire
dc.contributor.advisorWard, Kim
dc.contributor.authorDhanraj, Keshnee
dc.date.accessioned2021-03-09T12:52:15Z
dc.date.available2021-03-09T12:52:15Z
dc.date.issued2021
dc.identifier.urihttp://hdl.handle.net/11394/7956
dc.descriptionMagister Pharmaceuticae - MPharmen_US
dc.description.abstractMedicines have to be regulated in an effort to monitor their quality, safety, and efficacy. The process of medicines registration is lengthy, costly, and document-heavy. Many countries have limited expertise and resources at national medicines regulatory authorities (NMRAs) and some countries have adopted unified approaches to medicines registration legislation. Harmonised guidelines and initiatives have been adopted in South Africa and the Southern African Development Community (SADC). However, there are no studies that have identified the effects of these initiatives and guidelines on major stakeholders such as the pharmaceutical industry and regulators.en_US
dc.language.isoenen_US
dc.publisherUniversity of the Western Capeen_US
dc.subjectPerceptions of medicines registrationen_US
dc.subjectMedicines registration harmonisation in SADCen_US
dc.subjectRegulatory affairsen_US
dc.subjectRegulatorsen_US
dc.titlePerceptions of the pharmaceutical industry and regulators in South Africa towards registration harmonisation in the Southern African Development Community (SADC)en_US
dc.rights.holderUniversity of the Western Capeen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record